Sign in
WithdrawnNo phase

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Withdrawn
Started
May 2025
Ended
Dec 2025
Type of study
Interventional
Treatments tested
  • Virtual Reality
Record updated
27 May 2026
Why it stopped
Study never initiaed.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Participants must be at least 18 years old
  • Patients must have been clinically evaluated by a Yale Interventional Psychiatry Service physician who has deemed them appropriate to receive TMS for the treatment of OCD
  • Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements

Who cannot take part

  • Was previously enrolled/randomized into the study
  • Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content
  • History of seizure disorder
  • Dementia or other cognitive disorder or intellectual disability that would impair the subject's ability to understand the study procedure (per investigator judgment)
  • Any other medical or psychiatric comorbidity that the investigator judges would put the participant at additional undue risk due to study participation or would impair subject's ability to participate in the study
  • Difficulty in understanding spoken or written English
  • Pregnancy
  • Unable to provide informed consent
  • Any implanted medical device, risk of interference with which by the VR device in the investigator's judgment can put patient at additional undue risk

Where in United States

  • Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unitNew Haven, United States

About the trial

What the trial wants to find out

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

The group in the trial

  • Treatment GroupTreatment being tested

    This single arm will include all participants of the study, who will all receive the intervention

    Treatment: Virtual Reality

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
27 May 2026